Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.

Bergenfelz, Caroline LU orcid ; Gaber, Alexander LU ; Allaoui, Roni LU ; Mehmeti, Meliha LU ; Jirström, Karin LU orcid ; Leanderson, Tomas LU and Leandersson, Karin LU orcid (2015) In British Journal of Cancer 113(8). p.1234-1243
Abstract
Breast cancer is the most common cancer form among women today. Depending on hormone receptor status, breast cancers are divided into different subtypes with vastly varying prognosis. S100A9 is a calcium-binding protein that is associated with inflammation and expressed not only in myeloid cells but also in some tumours. The role for S100A9 in the malignant cells is not well characterised; however, previous studies have shown that the protein could have important immune-modulating properties.
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
British Journal of Cancer
volume
113
issue
8
pages
1234 - 1243
publisher
Nature Publishing Group
external identifiers
  • pmid:26448179
  • wos:000363445400012
  • scopus:84945470244
  • pmid:26448179
ISSN
1532-1827
DOI
10.1038/bjc.2015.346
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Cancer immunology (013031800), Experimental Infection Medicine (013017505), Faculty of Medicine (000022000), Pathology, (Lund) (013030000), Immunology (013212020)
id
04af3d7a-6ab4-4f40-a742-0217a169a9ec (old id 8158557)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26448179?dopt=Abstract
date added to LUP
2016-04-01 09:48:08
date last changed
2024-01-06 00:11:24
@article{04af3d7a-6ab4-4f40-a742-0217a169a9ec,
  abstract     = {{Breast cancer is the most common cancer form among women today. Depending on hormone receptor status, breast cancers are divided into different subtypes with vastly varying prognosis. S100A9 is a calcium-binding protein that is associated with inflammation and expressed not only in myeloid cells but also in some tumours. The role for S100A9 in the malignant cells is not well characterised; however, previous studies have shown that the protein could have important immune-modulating properties.}},
  author       = {{Bergenfelz, Caroline and Gaber, Alexander and Allaoui, Roni and Mehmeti, Meliha and Jirström, Karin and Leanderson, Tomas and Leandersson, Karin}},
  issn         = {{1532-1827}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1234--1243}},
  publisher    = {{Nature Publishing Group}},
  series       = {{British Journal of Cancer}},
  title        = {{S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.}},
  url          = {{https://lup.lub.lu.se/search/files/1267608/8866305}},
  doi          = {{10.1038/bjc.2015.346}},
  volume       = {{113}},
  year         = {{2015}},
}